Complementary therapies in medicine · 2020
Acupuncture for pediatric sickle cell pain management: A promising non-opioid therapy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tsai Shiu-Lin, Bombacie Michelle, Licursi Maureen, Qian Yunzhi, Stiles Gayla Marie, Lee Margaret T
Аннотация
OBJECTIVE: To describe the use of acupuncture for pain management in children with sickle cell disease.
DESIGN: A retrospective chart review of a single-institution experience on the use of acupuncture in pediatric patients with sickle cell disease was evaluated between 2012-2019. Demographic characteristics, presenting pain location, pain scores pre- and post-acupuncture, and adverse events were collected.
SETTING: Columbia University Medical Center, NewYork-Presbyterian Morgan Stanley Children's Hospital Pediatric Hematology outpatient and inpatient units.
INTERVENTIONS: Acupuncture was performed by six licensed acupuncturists. Point prescriptions were based on pain location, philosophies of Traditional Chinese Medicine and Japanese Style of Kiiko Matsumoto acupuncture.
MAIN OUTCOME MEASURES: Pain reduction as measured by two Verbal Pain Scales.
RESULTS: Ninety acupuncture treatments were administered to twenty-four patients with sickle cell disease: median age 17.5 years, 62 % female, 37.5 % African American, 50 % Hispanic. The mean treatment duration was 18.5 ± 4.8 min. Fifty-five treatments had documented pre/post-acupuncture pain scores. Pain reduction was achieved in 65.5 % of these treatments. A 0-10 pain scale used in 13 treatments reported a mean pre-acupuncture score of 7.31 ± 1.75, post-acupuncture score of 6.08 ± 1.85, and a mean pain score change of 1.23 ± 1.09 (p = 0.11); A 0-4 pain scale used in 42 treatments reported a mean pre-acupuncture pain score of 3.31 ± 0.72, post-acupuncture score of 2.33 ± 0.98, and a mean pain score change of 0.98 ± 0.99 (p < 0.0001). No adverse events were noted.
CONCLUSION: Acupuncture therapy decreased pain for our patients with sickle cell disease, providing a safe non-opioid therapeutic option.
DESIGN: A retrospective chart review of a single-institution experience on the use of acupuncture in pediatric patients with sickle cell disease was evaluated between 2012-2019. Demographic characteristics, presenting pain location, pain scores pre- and post-acupuncture, and adverse events were collected.
SETTING: Columbia University Medical Center, NewYork-Presbyterian Morgan Stanley Children's Hospital Pediatric Hematology outpatient and inpatient units.
INTERVENTIONS: Acupuncture was performed by six licensed acupuncturists. Point prescriptions were based on pain location, philosophies of Traditional Chinese Medicine and Japanese Style of Kiiko Matsumoto acupuncture.
MAIN OUTCOME MEASURES: Pain reduction as measured by two Verbal Pain Scales.
RESULTS: Ninety acupuncture treatments were administered to twenty-four patients with sickle cell disease: median age 17.5 years, 62 % female, 37.5 % African American, 50 % Hispanic. The mean treatment duration was 18.5 ± 4.8 min. Fifty-five treatments had documented pre/post-acupuncture pain scores. Pain reduction was achieved in 65.5 % of these treatments. A 0-10 pain scale used in 13 treatments reported a mean pre-acupuncture score of 7.31 ± 1.75, post-acupuncture score of 6.08 ± 1.85, and a mean pain score change of 1.23 ± 1.09 (p = 0.11); A 0-4 pain scale used in 42 treatments reported a mean pre-acupuncture pain score of 3.31 ± 0.72, post-acupuncture score of 2.33 ± 0.98, and a mean pain score change of 0.98 ± 0.99 (p < 0.0001). No adverse events were noted.
CONCLUSION: Acupuncture therapy decreased pain for our patients with sickle cell disease, providing a safe non-opioid therapeutic option.